Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance

Overview of attention for article published in Translational Neurodegeneration, September 2020

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 15,882 followers.

RT-QuIC real time quacking-induced conversion assay useful in finding biomarkers for #pdxtraffic anle138b - may be a useful molecule in #PD research @movedisorder https://t.co/vOAynHmVew https://t.co/iO1Ha92Uir

RT @ScienceofPD: An analyze the therapeutic efficacy of @AFFiRiSAG's PD03 (a new AFFITOPE® immunotherapy approach) either alone or in combi…

RT @ScienceofPD: An analyze the therapeutic efficacy of @AFFiRiSAG's PD03 (a new AFFITOPE® immunotherapy approach) either alone or in combi…

RT @ScienceofPD: An analyze the therapeutic efficacy of @AFFiRiSAG's PD03 (a new AFFITOPE® immunotherapy approach) either alone or in combi…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.